STUB1 and cyclic hematopoiesis: A subset of CH is driven by pathogenic mutations in myeloid malignancy-associated genes, which is termed CH of indeterminate potential (CHIP) and has been shown to be associated with hematologic cancers, cardiovascular disease (CVD), chronic obstructive pulmonary disease, and mortality, among other conditions2–4.